Twenty-one percent (21.3%) of participants tested positive for group B Streptococcus (GBS) on screening; 10.4% of participants had hypertension during pregnancy, and 16.5% were diagnosed with gestational diabetes (half of whom were treated with insulin). Here, INS is linked to gestational diabetes.